OptimizeRx Corporation (NASDAQ:OPRX) Q4 2024 Earnings Call Transcript March 12, 2025
OptimizeRx Corporation beats earnings expectations. Reported EPS is $0.3, expectations were $0.25.
Operator: Good morning, everyone, and thank you for joining OptimizeRx’s Fourth Quarter and Full Year Fiscal 2024 Earnings Conference Call. With us today is Chief Executive Officer, Steve Silvestro. He is joined by Chief Financial Officer, Ed Stelmakh; Chief Legal Officer, Marion Odense-Ford; and Senior Vice...
